Kiwon Jo

Title: Innovations by Kiwon Jo: Pioneering Cancer Treatment Solutions

Introduction

Kiwon Jo, an innovative inventor based in Yongin-si, South Korea, holds two notable patents that contribute significantly to cancer treatment. His work primarily focuses on developing solutions that inhibit cancer metastasis, showcasing his commitment to advancing medical science through groundbreaking research.

Latest Patents

Jo's latest patents include a method for inhibiting cancer metastasis through the administration of the extracellular domain DLK1 or a DLK1-FC fusion protein. This patent details a recombinant expression vector that integrates the extracellular soluble domain genes of DLK1 with IgG antibody Fc domain genes, allowing effective expression and purification of the DLK1-Fc fusion protein in 293E cells. Remarkably, this protein demonstrated efficacy in reducing cancer cell migration and exhibited higher stability compared to non-fusion proteins.

Another significant patent is an anticancer drug that contains an inhibitor of TMPRSS4 (transmembrane protease, serine 4). This invention highlights the potential of using TMPRSS4 inhibitors as a potent anticancer agent, which proves effective by inhibiting TMPRSS4 expression in cancer cells and consequently curbing cancer cell invasion and growth.

Career Highlights

Kiwon Jo works at the Korea Research Institute of Bioscience and Biotechnology. His dedication to research and development has led to significant advancements in the field of cancer treatment. His contributions are paving the way for more effective therapies that address critical challenges in oncology.

Collaborations

Throughout his career, Kiwon Jo has collaborated with talented individuals such as Young Woo Park and Ji Hyun Park. These partnerships enhance the innovative processes and outcomes of their research endeavors, demonstrating the power of teamwork in the pursuit of scientific breakthroughs.

Conclusion

Kiwon Jo’s contributions to cancer treatment through his patents affirm his role as a leading inventor in the biotechnology sector. His innovative approaches have the potential to make a significant impact on the lives of those affected by cancer, highlighting the importance of continued research and development in this critical field.